Just as structure-based drug design, combinatorial chemistry, Cryo-EM, and AlphaFold significantly advanced their respective eras, artificial intelligence (AI) now electrifies medicinal chemistry. While the fusion of AI and machine learning (ML) undeniably holds the power to accelerate drug target identification and new medicine discovery, their most significant opportunity lies in data interpretation. But is AI the magic bullet?